“Twenty-Four Vs. Fourty-Eight Weeks of Re-Therapy With Interferon Alpha 2b and Ribavirin in Interferon Alpha Monotherapy Relapsers With Chronic Hepatitis C”. 2003. Swiss Medical Weekly 133 (3334): 455-60. https://doi.org/10.4414/smw.2003.10300.